---

Andreas Seidel-Morgenstern

Director, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg

Andreas’ research focuses on developing concepts to better link the various steps involved in drug production. “I have a lot of ideas, and I am driven to evaluate their potential. This includes both theoretical concepts as well as practical implementations. I see it as a privilege that I can do this together with so many talented young people” says Andreas. “I would like to see more continuous production process applied in the pharma industry.”

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018